![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Global | Publication | March 2019
This report has been co-authored alongside DNV GL and released by the World Business Council for Sustainable Development (WBCSD).
This paper builds on previous WBCSD reports on corporate power purchase agreements (PPAs): Corporate Renewable Power Purchase Agreements: Scaling up globally (October 2016) and Innovation in Power Purchase Agreement Structures (March 2018). These reports cover the opportunities corporate PPAs offer, the obstacles that corporate buyers and developers face as they plan and negotiate PPAs, as well as innovations in corporate PPAs as the market grows and evolves. This paper adds an additional focus to the previous publications and discusses a particular type of PPA – a multi-technology PPA – and the manner in which developers and corporate buyers may increasingly be using it. We hope this will support continuing innovation in the way companies purchase renewable power for their operations.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023